Who Paid My Doc
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants with Moderate to Severe Plaque Psoriasis with Randomized Withdrawal and Retreatment
Research payments
$6,051,551
Through program year 2025, $6,051,551 in research payments was reported against A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants with Moderate to Severe Plaque Psoriasis with Randomized Withdrawal and Retreatment, across 762 payments, paid by Janssen Research & Development, LLC.
- Paid by
- Janssen Research & Development, LLC
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,222,476 | 273 |
| 2024 | Research | $4,469,860 | 457 |
| 2023 | Research | $359,214 | 32 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Benjamin Ehst Portland, OR Named on 53 payments
- Rosalyn George Wilmington, NC Named on 32 payments
- William Werschler Spokane, WA Named on 30 payments
- Angela Moore Arlington, TX Named on 29 payments
- Raja Sivamani Sacramento, CA Named on 27 payments
- Mark Lebwohl New York, NY Named on 27 payments
- Patricia Lee Webster, TX Named on 26 payments
- Vivian Laquer Irvine, CA Named on 26 payments
- Michael Bukhalo Rolling Meadows, IL Named on 25 payments
- Richard Beasley Rapid City, SD Named on 25 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.